PharmaCyte Biotech Discusses Future of Cannabis Research Program,...

PharmaCyte Biotech Discusses Future of Cannabis Research Program,...


PharmaCyte Biotech, Inc. , a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-BoxA , released today an interview-style Q&A article that discusses the company's Cannabis Research Program with Mark L. Rabe, MD, the Director of PharmaCyte's Cannabis Program Development. Given the latest research recently presented by Dr. Hyslop and his colleagues at the University of Northern Colorado , what are your thoughts about the future of PharmaCyte's Cannabis Research Program ? Dr. Mark Rabe : "The latest news from Dr. Hyslop and the UNC team was very encouraging.



from Biotech News